Atlas Trials

Add-on Therapy With Low Dose Fenfluramine in Lennox Gastaut Epilepsy

Clinical trial NCT02655198 · UNKNOWN

Trial details

NCT number
NCT02655198
Sponsor
KU Leuven
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
EpilepsyLennox Gastaut Syndrome
Start date
2016-01-01
Primary completion
2018-09-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.